Sterilray, Inc., a global leader in 222 nm Far-UV disinfection technology, is calling for early adopters to conduct university-supervised trials of its revolutionary pathogen-killing solution to combat the rapid spread of Avian Influenza (H5N1) in poultry barns. With outbreaks accelerating across the U.S. and worldwide, Sterilray proven technology offers a critical tool to mitigate the devastating effects of the virus—without the need for mass culling or extensive inoculation efforts.
Sterilray Far-UV 222 nm technology has already demonstrated its effectiveness in pig farms, significantly reducing viral transmission and preventing costly livestock losses. Unlike traditional UV-C, which can be harmful to animals and humans, Far-UV 222 nm has been extensively researched and is proven to be safe for humans and animals, while effectively neutralizing all forms of viral pathogens, bacteria, and mold.
“As Avian Flu threatens poultry farms at an unprecedented rate, immediate action is needed,” said Mike Olsen, CEO of Sterilray. “Our continuous barn disinfection technology provides a powerful, non-chemical, and safe approach to preventing outbreaks before they escalate. We are seeking forward-thinking poultry producers and research institutions to join us in rapid-deployment trials to validate and accelerate adoption of this breakthrough solution.”
Sterilray Far-UV 222 nm technology offers poultry producers a proactive defense, reducing the risk of infections and minimizing economic losses from depopulation efforts. By implementing this technology, farms can maintain productivity while safeguarding animal and worker health.
Call for Early Adopters
Sterilray is inviting poultry farmers, agricultural organizations, and research universities to participate in university-supervised trials. These trials will provide real-world data on the efficacy of 222 nm Far-UV technology in preventing Avian Flu outbreaks in poultry operations. Interested partners are encouraged to reach out immediately to take part in this vital initiative. Testing and deployment are ready to begin immediately.
